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Chronic kidney disease (CKD), impairment of kidney function, is a serious public 
health problem, and the assessment of genetic factors influencing kidney function has 
substantial clinical relevance. Here, we report a meta-analysis of genome-wide 
association studies for kidney function–related traits, including 71,149 east Asian 
individuals from 18 studies in 11 population-, hospital- or family-based cohorts, 
conducted as part of the Asian Genetic Epidemiology Network (AGEN). Our meta-
analysis identified 17 loci newly associated with kidney function–related traits, 
including the concentrations of blood urea nitrogen, uric acid and serum creatinine 
and estimated glomerular filtration rate based on serum creatinine levels (eGFRcrea) 
(P < 5.0 × 10−8). We further examined these loci with in silico replication in individuals 
of European ancestry from the KidneyGen, CKDGen and GUGC consortia, including a 
combined total of ~110,347 individuals. We identify pleiotropic associations among 
these loci with kidney function–related traits and risk of CKD. These findings provide 
new insights into the genetics of kidney function. 
At a glance 
1. Figure 1: Manhattan plots of the GWAS meta-analysis for kidney function–related 
traits.  
Shown are the −log10 (P values) of the SNPs for the concentrations of blood urea nitrogen, 
serum creatinine and uric acid, and for eGFRcrea. The genetic loci that satisfied the 
genome-wide significance threshold of P < 5.0 × 10−8 (gray horizontal dotted line) in the 
combined study of the GWAS meta-analysis and replication are labeled for each of the traits. 
The newly identified loci are colored red, and the previously known loci are colored blue. The 
SNPs for which the P value was smaller than 1.0 × 10−20 are indicated at the upper limit of 
each plot. 
2. Figure 2: Venn diagram of pleiotropic associations of the identified loci. 
 
Genetic loci identified in the study are classified on the basis of the results of the pleiotropic 
association study of kidney function–related traits (Table 2 and Supplementary Table 8). 
Genes that showed significant associations with risk for stage 3+ CKD are colored red. 
Main 
Chronic kidney disease—the impairment of kidney function—constitutes a serious public 
health burden on society worldwide, with increased risks of mortality and morbidity1, 2. 
Biochemical measures of kidney function that are commonly used in clinical practice include 
the concentrations of blood urea nitrogen, serum creatinine and uric acid and glomerular 
filtration rate (GFR). Heritability estimates have shown that genetic factors contribute 
significantly to interindividual variance in kidney function3, and recent developments in 
genome-wide association studies (GWAS) have identified a number of genetic loci 
associated with measurements of kidney function4, 5, 6, 7, 8, 9, 10, 11, 12, 13. However, most of these 
studies were conducted in populations of European ancestry4, 6, 7, 8, 10, 11, 12, 13, and the extension 
of GWAS approaches to non-European populations would provide an opportunity to discover 
additional loci. We report a large-scale meta-analysis of GWAS and a replication study of 
kidney function–related traits involving 71,149 east Asian subjects performed by AGEN9, 14, 15, 
16 in which 11 cohorts participated (BBJ, SP2, SiMES, SINDI, SCES, KARE, HEXA, TWSC, 
TWT2D, GenSalt and CAGE; Online Methods and Supplementary Note). 
In this study, we evaluated four kidney function–related traits (Supplementary Tables 1 and 
2): the concentrations of blood urea nitrogen (n = 57,178), uric acid (n = 33,074) and serum 
creatinine (n = 61.919) and eGFRcrea (n = 62,087). Blood urea nitrogen concentration 
reflects the amount of nitrogen in the blood and is related to protein metabolism, including 
excretion by the kidneys17. Uric acid is the end product of purine metabolism, and impaired 
renal excretion of uric acid leads to hyperuricemia. Epidemiological studies suggest that uric 
acid is a risk factor for various diseases, including gout and myocardial infarction13. Serum 
creatinine levels and eGFRcrea are the most common kidney function measures used for the 
definition of CKD1, 2, for which extensive genetic studies in European populations have been 
conducted4, 6, 7, 8. 
The GWAS meta-analysis included 51,327 east Asian individuals and evaluated 
approximately 2.4 million autosomal SNPs with a minor allele frequency (MAF) of ≥0.01. 
These SNPs were obtained by imputation of genotypes on the basis of HapMap Phase 2 
panels (Supplementary Tables 3 and 4). The inflation factors of the test statistics were 
modest (λGC = 1.060, 1.072, 1.079 and 1.031 for blood urea nitrogen, serum creatinine, 
eGFRcrea and uric acid, respectively), which suggested that population structures did not 
have a substantial impact on the results of the meta-analysis. Quantile-quantile plots of the P 
values indicated notable discrepancies in their tails from those anticipated under the null 
hypothesis of no association, indicating the presence of significant associations in the meta-
analysis (Supplementary Fig. 1). We identified 25 associations that satisfied the genome-
wide significance threshold of P < 5.0 × 10−8. Of these, eight, seven, six and four genetic loci 
were found to associated with blood urea nitrogen, serum creatinine, eGFRcrea and uric 
acid, respectively (Supplementary Table 5). 
We then performed an in silico replication study using data from an additional 19,822 east 
Asians for the loci that associated at P < 5.0 × 10−6 in the GWAS meta-analysis. Through the 
combined study of the GWAS meta-analysis and replication, we identified 32 significant 
associations at P < 5.0 × 10−8 (13, 8, 7 and 4 loci for blood urea nitrogen, serum creatinine, 
eGFRcrea and uric acid, respectively; Fig. 1 and Supplementary Table 5). We found that 
seven of these newly associated loci were associated with both serum creatinine 
concentration and eGFRcrea, with the same landmark SNPs involved at each locus, which 
reflects the close relationship between these two phenotypes (R2 = 0.76 for common log-
transformed values; Supplementary Table 6)1, 2. Among the loci identified in the combined 
analysis, associations at 15 loci were previously reported4, 5, 6, 7, 8, 9, 10, 11, 12, 13: LRIG1-KBTBD8, 
BCL6-LPP, RSPO3 and SLC14A2 for blood urea nitrogen concentration (smallest P = 8.8 × 
10−30 at BCL6-LPP); SHROOM3, WDR72, UMOD and BCAS3 for serum creatinine 
concentration (smallest P = 1.2 × 10−13 at WDR72); SHROOM3, WDR72, UMOD and BCAS3 
for eGFRcrea (smallest P = 6.0 × 10−13 at WDR72); and SLC2A9, ABCG2 and SLC22A12 for 
uric acid concentration (smallest P = 1.6 × 10−65 at SLC2A9). At the UMOD locus, the 
rs12917707 variant associated with eGFRcrea in Europeans4, 7 had a low MAF (<0.01) and 
was not evaluated in our GWAS meta-analysis. However, we identified another variant that 
showed a significant association with eGFRcrea (P = 3.6 × 10−10 at rs11864909; MAF = 0.19; 
r2 = 0.02 with rs12917707). 
Figure 1: Manhattan plots of the GWAS meta-analysis for kidney function–related 
traits.  
 Shown are the −log10 (P values) of the SNPs for the concentrations of blood urea nitrogen, 
serum creatinine and uric acid, and for eGFRcrea. The genetic loci that satisfied the 
genome-wide significance threshold of P < 5.0 × 10−8 (gray horizontal dotted line) in the 
combined study of the GWAS meta-analysis and replication are labeled for each of the traits. 
The newly identified loci are colored red, and the previously known loci are colored blue. The 
SNPs for which the P value was smaller than 1.0 × 10−20 are indicated at the upper limit of 
each plot. 
In addition, we identified 17 loci newly associated with kidney function–related traits (Table 1 
and Supplementary Fig. 2). Namely, we identified associations at nine loci for blood urea 
nitrogen concentration (MTX1-GBA, PAX8, MECOM, UNCX, MPPED2-DCDC5, C12orf51, 
WDR72, BCAS3 and GNAS at 1q22, 2q13, 3q26, 7p22, 11p14, 12q24.13, 15q21, 17q23 and 
20q13, respectively; smallest P = 4.5 × 10−16 at rs10767873 in MPPED2-DCDC5), four loci for 
serum creatinine concentration (the major histocompatibility (MHC) region, UNCX, MPPED2-
DCDC5 and ALDH2 at 6p21, 7p22, 11p14 and 12q24.2, respectively; smallest P = 4.6 × 10−11 
at rs10277115 in UNCX), three loci for eGFRcrea (the MHC region, UNCX and MPPED2-
DCDC5 at 6p21, 7p22 and 11p14, respectively; smallest P = 1.0 × 10−10 at rs10277115 in 
UNCX) and one locus for uric acid concentration (MAF at 16q23, P = 1.1 × 10−9 at rs889472). 
Combinations of these identified loci explained 1.3%, 0.54%, 0.55% and 2.3% of 
interindividual variance in blood urea nitrogen, serum creatinine, eGFRcrea and uric acid, 
respectively. 
To determine whether the associations that we observed were relevant to populations of 
European ancestry, we evaluated the newly associated loci (at P < 5.0 × 10−8 in our 
combined meta-analysis) in Europeans by using the results of studies by the KidneyGen (n = 
23,812 for serum creatinine concentration)6, CKDGen (n = 67,093 for eGFRcrea)7 and GUGC 
(n = 110,347 for uric acid concentration; A. Köttgen et al., personal communication) 
consortia. Nine of the 15 loci that reached P < 5.0 × 10−8 for serum creatinine, eGFRcrea and 
uric acid measures in our study also showed significant associations in the European study 
(P < 0.05/15 = 0.0033, Bonferroni correction for the number of loci with available results), 
including the MPPED2-DCDC5 locus for eGFRcrea (P = 5.3 × 10−8 at rs963837; 
Supplementary Table 5). 
We also evaluated the loci previously reported to be associated with kidney function 
measures, after excluding the 14 loci that had already been identified in our study 
(Supplementary Table 7)4, 5, 6, 7, 8, 9, 10, 11, 12, 13. Of the 31 loci evaluated, we replicated 
associations at 8 loci in our study (P < 0.05/31 = 0.0016, Bonferroni correction for the 
number of loci), including in CPS1, RGS14, STC1, RNASEH2C-OVOL1 and SLC6A13 for 
eGFRcrea and GCKR, LRP2 and LRRC16A-SLC17A1 for uric acid concentration. 
As the evaluated phenotypes reflect both common and unique biological aspects of kidney 
status, it is of interest to understand whether the loci associated with kidney function traits 
show pleiotropic patterns of associations18. We evaluated the associations of the identified 
loci within the evaluated kidney function–related traits and risk of stage 3+ CKD (defined as 
eGFRcrea of <60 ml/min/1.73 m2; Fig. 2, Table 2 and Supplementary Table 8)1, 2. Of 21 
unique loci, 9 yielded significant associations with three or more phenotypes (P < 0.05/21 = 
0.0024, Bonferroni correction for the number of loci). In particular, the ALDH2, C12orf51 and 
BCAS3 loci had significant associations with all of the evaluated kidney function–related 
traits. We also observed significant risk for CKD at several loci, including in MECOM, the 
MHC region, UNCX, WDR72, UMOD, MAF and GNAS. Because of the definition of CKD1, 2, 
previous studies assessed CKD risk primarily at the loci associated with serum creatinine 
concentration and eGFRcrea4, 6, 7, 8. However, our results suggest that genetic risk for CKD 
would also be contributed to by other kidney function–related loci, such as MAF and GNAS. 
Recent studies suggested the superiority of eGFR based on serum cystatin C concentration 
(eGFRcys) relative to eGFRcrea, especially for predicting GFR in subjects with normal or 
mildly reduced GFR, and assessment of the genetic factors underlying eGFRcys in east 
Asians would thus be warranted. 
Figure 2: Venn diagram of pleiotropic associations of the identified loci.  
 Genetic loci identified in the study are classified on the basis of the results of the pleiotropic 
association study of kidney function–related traits (Table 2 and Supplementary Table 8). 
Genes that showed significant associations with risk for stage 3+ CKD are colored red. 
In this study, we identified new associations at MTX1-GBA, PAX8, MECOM, the MHC region, 
UNCX, MPPED2-DCDC5, ALDH2, C12orf51, WDR72, MAF, BCAS3 and GNAS with kidney 
function–related traits. MTX1 has an essential role in embryonic development, and GBA 
encodes glucocerebrosidase, an enzyme mediating glycolipid metabolism19. Both are known 
as causal genes in Gaucher disease19, a lysosomal storage disease, although kidney 
function decline has not been implicated in pathogenesis. PAX8 is a member of the PAX 
gene family and is widely expressed in renal tissues20. MECOM (also known as EVI1) 
encodes a transcriptional regulator involved in hematopoiesis21. The MHC region contains a 
large number of genes related to the immune system, including human leukocyte antigen 
(HLA) genes. The SNP that was found to be associated with serum creatinine concentration 
and eGFRcrea (rs3828890) was located in the MHC class I region22 and was in moderate 
linkage disequilibrium with the HLA-DRB1*1302 and HLA-DQB1*0604 alleles (D′ > 0.65 and 
r2 > 0.40 for both alleles)23. UNCX encodes a paired-type homeobox transcription factor that 
has essential roles in skeleton formation and kidney development24. The function of MPPED2 
is as yet unknown, and DCDC5 encodes a protein with two doublecortin domains, which 
serve as protein-interaction platforms25. It is noteworthy that the MTX1-GBA, MECOM and 
MPPED2-DCDC5 loci have been reported to influence serum magnesium levels26, which are 
maintained by renal regulation of magnesium reabsorption. The loci in ALDH2, WDR72 and 
BCAS3 have been reported to be associated with some kidney function measures5, 7, 
although the biological roles of these genes in renal homeostasis have not been substantially 
explored. Although the function of the protein encoded by C12orf51 has not been examined, 
this locus was reported to be associated with serum lipid and liver enzyme concentrations in 
east Asians9. MAF encodes a leucine zipper transcription factor and has been implicated in 
the pathogenesis of minimal-change nephrotic syndrome (MCNS)27. Defects in MAF cause 
juvenile-onset pulverulent cataract as well as congenital cerulean cataract (CCA4)28. GNAS 
encodes the heterotrimeric G protein Gsα, and the associated locus in this gene is also 
associated with multiple metabolic traits, including blood pressure, in Europeans29. 
Nevertheless, other genes near each of the loci could also be candidates, and further 
functional assessment is desirable. 
In conclusion, in this large-scale meta-analysis in east Asian populations, we identified 
multiple loci newly associated with kidney function–related traits and pleiotropic associations. 
Our study should make an important contribution to the enhanced understanding of the 
genetic architecture of kidney function. 
URLs. 
International HapMap Project, http://hapmap.ncbi.nlm.nih.gov/; MACH and mach2qtl 
software, http://www.sph.umich.edu/csg/abecasis/MACH/index.html; IMPUTE and SNPTEST 
software, http://www.stats.ox.ac.uk/~marchini/software/gwas/gwas.html; BEAGLE software, 
http://faculty.washington.edu/browning/beagle/beagle.html; PLINK software, 
http://pngu.mgh.harvard.edu/~purcell/plink/; R statistical software, http://cran.r-project.org/; 
SNAP software, http://www.broadinstitute.org/mpg/snap/index.php. 
Methods 
Subjects. 
The 71,149 subjects included in the GWAS meta-analysis for kidney function–related traits (n 
= 57,178, 61,919, 62,087 and 33,074 for blood urea nitrogen, eGFRcrea and uric acid, 
respectively) were obtained from 18 studies conducted in the following 11 population-, 
hospital- or family-based cohorts of east Asian populations through the collaborations of 
AGEN9, 14, 15, 16: the BioBank Japan Project (BBJ), the Singapore Prospective Study Program 
(SP2), the Singapore Malay Eye Study (SiMES), the Singapore Indian Study (SINDI), the 
Singapore Chinese Eye Study (SCES), the Korea Association Resource project (KARE), the 
Health Examinee shared control study (HEXA), the Taiwan Super Control Study (TWSC), the 
Taiwan Type 2 Diabetes Consortium (TWT2D), the Genetic Epidemiology Network of Salt 
Sensitivity (GenSalt) and Cardio-metabolic Genome Epidemiology (CAGE). Of these, 51,327 
subjects were enrolled in the GWAS meta-analysis, and 19,822 subjects were enrolled in the 
in silico replication study. Some of the subjects were included in previous studies of east 
Asian populations9, 14, 15, 16. All participants in each cohort provided written informed consent 
for participation in the study, as approved by the ethical committees of each of the 
institutional review boards. Each study established a consensus on subject participation and 
phenotype definition and analytical protocol for the project. Detailed descriptions of the 
participating cohorts and the characteristics of the subjects are provided in Supplementary 
Tables 1 and 2 and in the Supplementary Note. Details of the European studies enrolled by 
the KidneyGen (n = 23,812 for serum creatinine concentration), CKDGen (n = 67,093 for 
eGFRcrea) and GUGC (n = 110,347 for uric acid concentration) consortia, including subject 
details and the study designs, have been described at length elsewhere (refs 6,7 and A. 
Köttgen et al., personal communication). 
Genotyping and quality control. 
Genotyping platforms and quality control criteria, including exclusion of closely related 
subjects and outliers in terms of ancestry and cutoff values for sample call rate, SNP call 
rate, MAF and Hardy-Weinberg equilibrium P value are provided for each study 
(Supplementary Table 3 and Supplementary Note). Genotype imputation was performed on 
the basis of the HapMap Phase 2 panels (Japanese in Tokyo, Japan (JPT) and Han Chinese 
in Beijing, China (CHB) populations, except for SiMES and SINDI, for which JPT, CHB, 
Yoruba in Ibadan, Nigeria (YRI) and Utah residents of Northern and Western European 
ancestry (CEU) populations were adopted) by using MACH, IMPUTE or BEAGLE software 
(see URLs). After imputation, we excluded SNPs with MAF of <0.01 or imputation quality 
score of R2 of <0.5 from each study. 
Phenotype modeling. 
Clinical information on the subjects, including age, gender and mean ± s.d. values for the 
kidney function–related traits, are provided (Supplementary Table 2). Collection methods for 
the clinical information in each of the cohorts are described (Supplementary Note). In this 
study, eGFRcrea was estimated on the basis of serum creatinine levels, using the Japanese 
coefficient-modified CKD Epidemiology Collaboration (CKD-EPI) equation2. We excluded 
subjects who were <18 or >85 years old, those who had eGFRcrea of <15 ml/min/1.73 m2 
and those who had undergone renal replacement therapy. Subjects with gastrointestinal 
bleeding, systemic infection or hepatic failure and subjects who had undergone uric acid–
lowering therapy (alloprinol, benzbromarone or probenecid) were also excluded from the 
analyses for blood urea nitrogen and uric acid concentration, respectively. 
Genome-wide association study. 
Associations of SNPs with common log-transformed values of blood urea nitrogen (mg/dl), 
serum creatinine (mg/dl), eGFRcrea (ml/min/1.73 m2) or non-transformed values of uric acid 
concentration (mg/dl) were assessed by linear regression models assuming additive effects 
of the allele dosages of the SNPs using mach2qtl, SNPTEST, PLINK or R statistical software 
(see URLs). For the subjects in the family-based cohort, generalized linear mixed models 
accounting for the family structure were applied. In the regression model, gender, age, 
drinking status (current drinker or not), smoking status (previous or current smoker or not), 
body mass index and other cohort-specific variables were incorporated as covariates 
(Supplementary Note). 
GWAS meta-analysis. 
In the GWAS meta-analysis, we included autosomal SNPs that satisfied quality control 
criteria in three or more GWAS for each of the traits, which yielded between 2.2 and 2.4 
million SNPs (Supplementary Table 4). Information about the SNPs, including the coded 
alleles, was oriented to the forward strand of the NCBI Build 36 reference sequence. GWAS 
meta-analysis was performed using an inverse variance–weighted method, assuming a 
fixed-effects model for study-specific effect estimates (β) and standard errors (SE) of the 
coded alleles of the SNPs, using a Java source code implemented by the authors30, 31. 
Genomic control corrections were carried out on test statistics from each of the GWAS using 
study-specific inflation factors (λGC) and were applied again to the results of the GWAS meta-
analysis (Supplementary Fig. 1)32. 
In silico replication study. 
The in silico replication study was conducted using additional independent east Asian 
subjects (Supplementary Tables 1 and 2) for the loci that satisfied P < 5.0 × 10−6 in the 
GWAS meta-analysis for each of the traits (17, 14, 14 and 6 loci for blood urea nitrogen, 
serum creatinine, eGFRcrea and uric acid, respectively; Supplementary Table 5). For each of 
the loci, the SNP that showed the most significant association was selected. The 
associations of the SNPs were assessed in the same manner as in the GWAS. The 
combined study of the GWAS meta-analysis and replication was conducted using an inverse 
variance method, assuming a fixed-effects model30, 31. The SNPs that satisfied P < 5.0 × 10−8 
in the combined study were considered to be significantly associated with the relevant kidney 
function–related trait, and the associations of these SNPs were further evaluated using data 
in European populations from the KidneyGen, CKDGen and GUGC consortia (refs 6,7 and A. 
Köttgen et al., personal communication). 
Estimation of explained variance. 
The interindividual variance in kidney function–related traits explained by the combination of 
the identified loci (P < 5.0 × 10−8 for each phenotype) was estimated using a genetic risk 
score model. We calculated the scores of the subjects enrolled in the in silico replication 
study by the BioBank Japan Project33 (BBJ_5 and BBJ_6; Supplementary Table 2) by 
summing the dosages of the effect alleles carried by the subjects, which were weighted by 
the effect sizes of the SNPs obtained from the GWAS meta-analysis. The explained variance 
was estimated from linear regression models on the covariate-adjusted phenotypes by the 
scores. 
Pleiotropic association analysis for kidney function–related phenotypes. 
For the genetic loci that showed associations at P < 5.0 × 10−8 in the combined study, 
pleiotropic associations with the kidney function–related traits and with risk for stage 3+ CKD 
(defined as eGFRcrea of <60 ml/min/1.73m2)1, 2 were assessed. Associations with CKD risk 
were assessed using logistic regression models, incorporating the covariates using the 
subjects obtained from the BioBank Japan Project33 (BBJ_1– BBJ_6; Supplementary Table 
2). 
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